https://www.selleckchem.com/pr....oducts/delamanid.htm
As current nomograms, based on preselected patient datasets, perform poorly in prospective settings, these tools should be used with caution. Patient decision aids are an underutilized tool in decision-making. Localized RCC requires highly nuanced treatment decision-making, balancing patient- and tumor-specific clinical variables against indirect structural influences to provide optimal patient care. With expanding treatment options for localized kidney cancer, treatment decision is highly nuanced and requires shared decision-making.
Like
Comment
Share
